Skip to main content
Journal cover image

Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.

Publication ,  Journal Article
Stefanovic, A; Davis, J; Murray, T; Markoe, A; Lossos, IS
Published in: Br J Haematol
October 2010

Duke Scholars

Published In

Br J Haematol

DOI

EISSN

1365-2141

Publication Date

October 2010

Volume

151

Issue

1

Start / End Page

103 / 106

Location

England

Related Subject Headings

  • Prospective Studies
  • Middle Aged
  • Methotrexate
  • Male
  • Lymphoma, Non-Hodgkin
  • Immunology
  • Humans
  • Female
  • Eye Neoplasms
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stefanovic, A., Davis, J., Murray, T., Markoe, A., & Lossos, I. S. (2010). Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience. Br J Haematol, 151(1), 103–106. https://doi.org/10.1111/j.1365-2141.2010.08321.x
Stefanovic, Alexandra, Janet Davis, Timothy Murray, Arnold Markoe, and Izidore S. Lossos. “Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.Br J Haematol 151, no. 1 (October 2010): 103–6. https://doi.org/10.1111/j.1365-2141.2010.08321.x.
Stefanovic, Alexandra, et al. “Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.Br J Haematol, vol. 151, no. 1, Oct. 2010, pp. 103–06. Pubmed, doi:10.1111/j.1365-2141.2010.08321.x.
Journal cover image

Published In

Br J Haematol

DOI

EISSN

1365-2141

Publication Date

October 2010

Volume

151

Issue

1

Start / End Page

103 / 106

Location

England

Related Subject Headings

  • Prospective Studies
  • Middle Aged
  • Methotrexate
  • Male
  • Lymphoma, Non-Hodgkin
  • Immunology
  • Humans
  • Female
  • Eye Neoplasms
  • Combined Modality Therapy